Plasma glutamine levels in patients after non-elective or elective ICU admission: an observational study

Hanneke Buter, Andries J Bakker, W Peter Kingma, Matty Koopmans, E Christiaan Boerma, Hanneke Buter, Andries J Bakker, W Peter Kingma, Matty Koopmans, E Christiaan Boerma

Abstract

Background: A low plasma glutamine level at the time of acute admission to the intensive care unit (ICU) is an independent predictor of an unfavourable outcome in critically ill patients. The primary objective of this study was to determine whether there are differences in plasma glutamine levels upon non-elective or elective ICU admission. The secondary objective was to compare glutamine levels over time, and to determine correlations between glutamine levels and the severity of illness and presence of infection in ICU patients.

Methods: We performed a single-centre observational study in a closed-format, 22-bed, mixed ICU. Plasma glutamine levels were measured at admission and every morning at 6.00 a.m. during the ICU stay. We aimed to include at least 80 patients per group. The study was approved by the local Medical Ethics Committee.

Results: In 88 patients after elective surgery, the median plasma glutamine level at admission was significantly higher compared with that in 90 non-elective patients (0.43 mmol/l [0.33-0.55 mmol/l] versus 0.25 mmol/l [0.09-0.37 mmol/l], P = 0.001). During the ICU stay, plasma glutamine levels remained significantly higher in elective patients than in non-elective patients. There was a significant correlation between the APACHE IV score and glutamine levels (R = 0.52, P < 0.001). Moreover, backward linear regression analysis showed that this correlation was independently associated with the APACHE IV score and the presence of infection, but not with the type of admission.

Conclusions: Plasma glutamine levels are significantly lower after non-elective admission compared with elective admission to the ICU. A considerable amount of elective and non-elective patients have decreased plasma glutamine levels, but this is not independently associated with the type of admission. In contrast to previous studies, we found that plasma glutamine levels were determined by the severity of illness and the presence of an infection.

Trial registration: ClinicalTrials.gov, number NCT02310035.

Keywords: Elective surgery; Intensive care unit; Non-elective admission; Plasma glutamine levels.

References

    1. Oliveira GP, Dias CM, Pelosi P, Rocco PRM. Understanding the mechanisms of glutamine action in critically ill patients. An Acad Bras Cienc. 2010;82:417–30. doi: 10.1590/S0001-37652010000200018.
    1. Wernerman J. Glutamine supplementation to critically ill patients? Crit Care. 2014;18:214. doi: 10.1186/cc13781.
    1. Oudemans-van Straaten HM, Bosman RJ, Treskes M, van der Spoel HJI, Zandstra DF. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med. 2001;27:84–90. doi: 10.1007/s001340000703.
    1. Rodas PC, Rooyackers O, Hebert C, Norberg A, Wernerman J. Glutamine and glutathione at ICU admission in relation to outcome. Clin Sci. 2012;122:591–7. doi: 10.1042/CS20110520.
    1. Goeters C, Wenn A, Mertes N, Wempe C, van Aken H, Stehle P, et al. Parenteral l-alanyl-l-glutamine improves 6 month outcome in critically ill patients. Crit Care Med. 2002;30:2032–7. doi: 10.1097/00003246-200209000-00013.
    1. Wilmore DW, Shabert JK. Role of glutamine in immunologic responses. Nutrition. 1998;14:618–26. doi: 10.1016/S0899-9007(98)00009-4.
    1. Buijs N, Wörner EA, Brinkmann SJ, Luttikhold J, van der Meij BS, Houdijk AP, van Leeuwen PA. Novel nutritional substrates in surgery. Proc Nutr Soc. 2013;72:277–87. doi: 10.1017/S0029665112003047.
    1. Schricker T, Lattermann R. Perioperative catabolism. Can J Anaesth. 2015;62:182–93. doi: 10.1007/s12630-014-0274-y.
    1. Kreymann KG, Berger MM, Deutz NEP, et al. ESPEN guidelines on enteral nutrition: Intensive Care. Clin Nutr. 2006;25:210–23. doi: 10.1016/j.clnu.2006.01.021.
    1. Berger MM, Pichard C. Best timing for energy provision during critical illness. Crit Care. 2012;16:215.
    1. Franke A, Lante W, Fackeldey V, Becker HP, Kurig E, Zoller LG, et al. Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know? Eur J Cardiothorac Surg. 2005;28:569–75. doi: 10.1016/j.ejcts.2005.07.007.
    1. Engel JM, Pitz S, Muhling J, Menges T, Martens F, Kwapisz M, Hempelmann G. Role of glutamine administration on T-cell derived inflammatory response after cardiopulmonary bypass. Clin Nutr. 2009;28:15–20. doi: 10.1016/j.clnu.2008.08.007.
    1. Parry-Billings M, Baigrie R, Lamont PM, Morris PJ, Newsholme EA. Effects of major and minor surgery on plasma glutamine and cytokine levels. Arch Surg. 1992;127:1237–40. doi: 10.1001/archsurg.1992.01420100099017.
    1. Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systemic review of the evidence. Crit Care Med. 2002;30:2022–9. doi: 10.1097/00003246-200209000-00011.
    1. Andrews PJ, Avenell A, Noble DW, et al. Randomised trial of glutamine, selenium, or both to supplement parenteral nutrition for critically ill patients. BMJ. 2011;342:d1542. doi: 10.1136/bmj.d1542.
    1. Heyland D, Muscedere J, Wischmeyer PE, et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 2013;368:1489–97. doi: 10.1056/NEJMoa1212722.
    1. Van den Berghe G. Low glutamine levels during critical illness – adaptive or maladaptive? N Engl J Med. 2013;368:1549–50. doi: 10.1056/NEJMe1302301.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться